-
Alzheimer's drug researcher accused of 'egregious misconduct'
Clinical trials for simufilam, an Alzheimer's drug made by Cassava Sciences, will continue even after one of its lead researchers has been accused of "long-standing and egregious misconduct in data management and record keeping," The New York Times reported Oct. 14. -
Cuban's Cost Plus partners with Alto Pharmacy to expand access
San Francisco-based Alto Pharmacy, will now accept Team Cuban Cards from Mark Cuban Cost Plus Drug Co., members, according to an Oct. 16 news release. -
Common antibiotic may be linked to neurological dysfunction, study says
Researchers found very little difference in the outcomes of patients hospitalized with acute kidney injuries who received different antibiotics — cefepime or piperacillin-tazobactam — as treatment, according to the study published Oct. 14 in JAMA. -
Walgreens, CVS workers plan nationwide strike
Pharmacy employees at Walgreens and CVS are in talks to organize nationwide walkouts and protests in late October, people familiar with the matter told CNBC. -
Kaiser pharmacy workers continue 3-week strike, approve to double it
As hundreds of pharmacy workers for Kaiser Permanente continue striking for up to three weeks in Oregon and Southwest Washington, their union approved another strike that could last almost four more weeks. -
Mounjaro helps patients lose 60+ pounds in study
Mounjaro (tirzepatide), Eli Lilly's Type 2 diabetes drug, helped obese and overweight adults lose an average of 64 pounds after 84 weeks in a phase 3 trial. -
The cost of defending a pharmacist license grew 43% in 5 years
Liability claims and incidents involving pharmacists have risen in individual cost, according to a new industry report. -
Paxlovid popularity dwindles
When Pfizer's antiviral Paxlovid entered the U.S. market in December 2021, it quickly became the preferred COVID-19 drug. Nearly two years later, physicians aren't writing many prescriptions for the therapy once touted as a "breakthrough," NBC News reported. -
Texas pharmacy must pay $275K over unlawful opioid distribution
A San Antonio-based pharmacy and pharmacist have been ordered by a federal court to pay $275,000 for the unlawful distribution of opioid and benzodiazepine prescriptions, according to an Oct. 11 news release. -
UVA Health selects chief pharmacy officer
Danielle Griggs, PharmD, will be the chief pharmacy officer of Charlottesville, Va.-based UVA Health, effective Oct. 18. -
HCA, Harvard Pilgrim, UC Irvine partner on research to prevent HAIs
An antibiotic ointment administered through the nose is effective in protecting critically ill patients in the ICU from Staphylococcus aureus infections, according to an Oct. 10 HCA Healthcare news release. -
Bristol Myers Squibb to buy cancer drugmaker for $5.8B
Bristol Myers Squibb, one of the world's largest pharmaceutical companies, plans to acquire oncology drugmaker Mirati Therapeutics for up to $5.8 billion. -
CarelonRx: Collaboration between payers, specialty pharmacies can help people lead healthier lives
We all know someone affected by a complex illness. Cancer. Crohn's disease. Multiple sclerosis. -
California is 1st state to require pharmacists to report errors
California is the first state to require pharmacists to report every prescription mistake. -
Walgreens walkout enters last day: 5 notes
After seeing success from CVS pharmacy workers calling out of work over staffing concerns in Kansas City, Walgreens employees organized a walkout — but it's unclear whether the scattered labor action will result in change. -
Employer coverage of weight-loss drugs set to double in 2024
Forty-three percent of employers plan to cover weight loss drugs in 2024, nearly double the proportion of employers that cover them now, according to newly released survey findings from Accolade. -
Mark Cuban's pharmacy racks up collaborators
Nearly two years after Mark Cuban launched a mail-order pharmacy with low-cost medications, the entrepreneur and "Shark Tank" star has secured more than a dozen collaborators. -
DEA, HHS issue 2nd extension of controlled substances via telehealth
The U.S. Drug Enforcement Agency is, for a second time, extending clinicians' ability to prescribe controlled substances using telehealth services, according to a revised rule the agency published. -
5 drugs now in shortage
Since mid-September, drugmakers have reported five new drug shortages, including medications for lung cancer, hypertension and eye infections. -
Walgreens pharmacists plan walkout
An unclear number of Walgreens pharmacies might close Oct. 9-11 after pharmacists shared plans through social media apps, emails and fliers to stage a walkout, according to CNN.
Page 7 of 50